Adebajo SB, Adebiyi R, Chama J, Bello S, Ononaku U, Aka A, Lai S, Baral SD, Dyer TV, Crowell TA, Nowak RG, Charurat M; TRUST/RV368 Study Group. Depression and Sexual Stigma Are Associated With Cardiometabolic Risk Among Sexual and Gender Minorities Living With HIV in Nigeria. J Acquir Immune Defic Syndr. 2023 Jan 1;92(1):50-58. doi: 10.1097/QAI.0000000000003096. PMID: 36150037.
Chachage M, Parikh AP, Mahenge A, Bahemana E, Mnkai J, Mbuya W, Mcharo R, Maganga L, Mwamwaja J, Gervas R, Kibuuka H, Maswai J, Singoei V, Iroezindu M, Fasina A, Esber A, Dear N, Imbach M, Crowell TA, Hern J, Song X, Hoelscher M, Polyak CS, Ake JA, Geldmacher C; AFRICOS Study Group. High-risk human papillomavirus (HPV) genotype distribution among women living with and at risk for HIV in the African cohort study. AIDS. 2022 Dec 1. doi: 10.1097/QAD.0000000000003437. Online ahead of print. PMID: 36398743.
Yu J, Thomas PV, McMahan K, Jacob-Dolan C, Liu J, He X, Hope D, Martinez EJ, Chen WH, Sciacca M, Hachmann NP, Lifton M, Miller J, Powers OC, Hall K, Wu C, Barrett J, Swafford I, Currier JR, King J, Corbitt C, Chang WC, Golub E, Rees PA, Peterson CE, Hajduczki A, Hussin E, Lange C, Gong H, Matyas GR, Rao M, Paquin-Proulx D, Gromowski GD, Lewis MG, Andersen H, Davis-Gardner M, Suthar MS, Michael NL, Bolton DL, Joyce MG, Modjarrad K, Barouch DH. Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN. Sci Adv. 2022 Nov 25;8(47):eade4433. doi: 10.1126/sciadv.ade4433. Epub 2022 Nov 23. PMID: 36417525.
Kimanga DO, Oramisi VA, Hassan AS, Mugambi MK, Miruka FO, Muthoka KJ, Odhiambo JO, Yegon PK, Omoro GO, Mbaire C, Masamaro KM, Njogo SM, Barker JL, Ngugi CN. Uptake and effect of universal test-and-treat on twelve months retention and initial virologic suppression in routine HIV program in Kenya. PLoS One. 2022 Nov 22;17(11):e0277675. doi: 10.1371/journal.pone.0277675. eCollection 2022. PMID: 36413522.
Cable J, Saphire EO, Hayday AC, Wiltshire TD, Mousa JJ, Humphreys DP, Breij ECW, Bruhns P, Broketa M, Furuya G, Hauser BM, Mahévas M, Carfi A, Cantaert T, Kwong PD, Tripathi P, Davis JH, Brewis N, Keyt BA, Fennemann FL, Dussupt V, Sivasubramanian A, Kim PM, Rawi R, Richardson E, Leventhal D, Wolters RM, Geuijen CAW, Sleeman MA, Pengo N, Donnellan FR. Antibodies as drugs-a Keystone Symposia report. Ann N Y Acad Sci. 2022 Nov 16. doi: 10.1111/nyas.14915. Online ahead of print. PMID: 36382536.
Kamau E, Chaudhury S, Bolton JS, Slike BM, Jian N, Eller MA, Eller LA, Ake J, Robb ML, Krebs SJ, Bergmann-Leitner ES. Susceptibility to Human Immunodeficiency Virus Type 1 Acquisition Linked to Malaria Exposure: A Case-Control Study. Clin Infect Dis. 2022 Nov 14;75(10):1834-1837. doi: 10.1093/cid/ciac384. PMID: 35594548.
Ara Jo-Pereira M, Sheikh V, Sereti I, Barreto-Duarte B, Arriaga MÍB, Tib Rcio R, Vinhaes CL, Pinto-de-Almeida M, Wang J, Rupert A, Roby G, Shaffer D, Ananworanich J, Phanuphak N, Sawe F, Andrade BB. Association between severe anaemia and inflammation, risk of IRIS and death in persons with HIV: A multinational cohort study. EBioMedicine. 2022 Nov;85:104309. doi: 10.1016/j.ebiom.2022.104309. Epub 2022 Oct 22. PMID: 36283285.
Allahna E, Nicole D, Neha S, Hannah K, Jonah M, John O, Valentine S, Emmanuel B, Michael I, Trevor A C, Christina S P, Joseph S C, Julie A A; AFRICOS Study Group. Brief Report: Virologic Impact of the Dolutegravir Transition: Prospective Results From the Multinational African Cohort Study. J Acquir Immune Defic Syndr. 2022 Nov 1;91(3):285-289. doi: 10.1097/QAI.0000000000003065. Epub 2022 Aug 18. PMID: 35980350.
Lewitus E, Hoang J, Li Y, Bai H, Rolland M. Optimal sequence-based design for multi-antigen HIV-1 vaccines using minimally distant antigens. PLoS Comput Biol. 2022 Oct 31;18(10):e1010624. doi: 10.1371/journal.pcbi.1010624. eCollection 2022 Oct. PMID: 36315492.
Andagalu B, Lu P, Onyango I, Bergmann-Leitner E, Wasuna R, Odhiambo G, Chebon-Bore LJ, Ingasia LA, Juma DW, Opot B, Cheruiyot A, Yeda R, Okudo C, Okoth R, Chemwor G, Campo J, Wallqvist A, Akala HM, Ochiel D, Ogutu B, Chaudhury S, Kamau E. Age-dependent antibody profiles to plasmodium antigens are differentially associated with two artemisinin combination therapy outcomes in high transmission setting. Front Med (Lausanne). 2022 Oct 13;9:991807. doi: 10.3389/fmed.2022.991807. eCollection 2022. PMID: 36314027.
Concepcion T, Velloza J, Kemp CG, Bhat A, Bennett IM, Rao D, Polyak CS, Ake JA, Esber A, Dear N, Maswai J, Owuoth J, Sing'oei V, Bahemana E, Iroezindu M, Kibuuka H, Collins PY. Perinatal Depressive Symptoms and Viral Non-suppression Among a Prospective Cohort of Pregnant Women Living with HIV in Nigeria, Kenya, Uganda, and Tanzania. AIDS Behav. 2022 Oct 9. doi: 10.1007/s10461-022-03810-6. Online ahead of print. PMID: 36210392.
Paul R, Cho K, Bolzenius J, Sacdalan C, Ndhlovu LC, Trautmann L, Krebs S, Tipsuk S, Crowell TA, Suttichom D, Colby DJ, Premeaux TA, Phanuphak N, Chan P, Kroon E, Vasan S, Hsu D, Carrico A, Valcour V, Ananworanich J, Robb ML, Ake JA, Sriplienchan S, Spudich S; RV254/SEARCH 010 Study Team. Individual Differences in CD4/CD8 T-Cell Ratio Trajectories and Associated Risk Profiles Modeled From Acute HIV Infection. Psychosom Med. 2022 Oct 1;84(8):976-983. doi: 10.1097/PSY.0000000000001129. Epub 2022 Jul 6. PMID: 36162059.
Takata H, Kakazu JC, Mitchell JL, Kroon E, Colby DJ, Sacdalan C, Bai H, Ehrenberg PK, Geretz A, Buranapraditkun S, Pinyakorn S, Intasan J, Tipsuk S, Suttichom D, Prueksakaew P, Chalermchai T, Chomchey N, Phanuphak N, de Souza M, Michael NL, Robb ML, Haddad EK, Crowell TA, Vasan S, Valcour VG, Douek DC, Thomas R, Rolland M, Chomont N, Ananworanich J, Trautmann L; RV254/SEARCH010, RV304/ SEARCH013, and SEARCH011 study groups. Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8+ T cells. EBioMedicine. 2022 Oct;84:104253. doi: 10.1016/j.ebiom.2022.104253. Epub 2022 Sep 8. PMID: 36088683.
Adebajo SB, Adebiyi R, Chama J, Bello S, Ononaku U, Aka A, Lai S, Baral SD, dyeR TV, Crowell TA, Nowak RG, Charurat M; TRUST/RV368 Study Group. Depression and Sexual Stigma are Associated with Cardiometabolic Risk among Sexual and Gender Minorities Living with HIV in Nigeria. J Acquir Immune Defic Syndr. 2022 Sep 23. doi: 10.1097/QAI.0000000000003096. Online ahead of print. PMID: 36150037.
Mdluli T, Li Y, Pinyakorn S, Reeves DB, Cardozo-Ojeda EF, Yates A, Intasan J, Tipsuk S, Phanuphak N, Sacdalan C, Colby DJ, Kroon E, Crowell TA, Thomas R, Robb ML, Ananworanich J, de Souza M, Phanuphak P, Stieh DJ, Tomaka FL, Trautmann L, Ake JA, Hsu DC, Francisco LV, Vasan S, Rolland M. Acute HIV-1 infection viremia associate with rebound upon treatment interruption. Med (N Y). 2022 Sep 9;3(9):622-635.e3. doi: 10.1016/j.medj.2022.06.009. Epub 2022 Jul 22. PMID: 35870446.
Takata H, Kakazu JC, Mitchell JL, Kroon E, Colby DJ, Sacdalan C, Bai H, Ehrenberg PK, Geretz A, Buranapraditkun S, Pinyakorn S, Intasan J, Tipsuk S, Suttichom D, Prueksakaew P, Chalermchai T, Chomchey N, Phanuphak N, de Souza M, Michael NL, Robb ML, Haddad EK, Crowell TA, Vasan S, Valcour VG, Douek DC, Thomas R, Rolland M, Chomont N, Ananworanich J, Trautmann L; RV254/SEARCH010, RV304/ SEARCH013, and SEARCH011 study groups. Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8+ T cells. EBioMedicine. 2022 Sep 8;84:104253. doi: 10.1016/j.ebiom.2022.104253. Online ahead of print. PMID: 36088683.
Andagalu B, Watson OJ, Onyango I, Opot B, Okoth R, Chemwor G, Sifuna P, Juma D, Cheruiyot A, Yeda R, Okudo C, Wafubwa J, Yalwala S, Abuom D, Ogutu B, Cowden J, Akala HM, Kamau E. Reply to Blanken et al. Clin Infect Dis. 2022 Sep 7:ciac741. doi: 10.1093/cid/ciac741. Online ahead of print.PMID: 36069376
Esber A, Dear N, Shah N, Kibuuka H, Maswai J, Owuoth J, Singoei V, Bahemana E, Iroezindu M, Crowell TA, Polyak CS, Cavanaugh JS, Ake JA; AFRICOS Study Group. Virologic impact of the dolutegravir transition: prospective results from the multinational African Cohort Study. J Acquir Immune Defic Syndr. 2022 Aug 3. doi: 10.1097/QAI.0000000000003065. Online ahead of print. PMID: 35980350.
Chancharoenthana W, Sutnu N, Visitchanakun P, Sawaswong V, Chitcharoen S, Payungporn S, Schuetz A, Schultz MJ, Leelahavanichkul A. Critical roles of sepsis-reshaped fecal virota in attenuating sepsis severity. Front Immunol. 2022 Aug 2;13:940935. doi: 10.3389/fimmu.2022.940935. eCollection 2022. PMID: 35983067.
Li SS, Hickey A, Shangguan S, Ehrenberg PK, Geretz A, Butler L, Kundu G, Apps R, Creegan M, Clifford RJ, Pinyakorn S, Eller LA, Luechai P, Gilbert PB, Holtz TH, Chitwarakorn A, Sacdalan C, Kroon E, Phanuphak N, de Souza M, Ananworanich J, O'Connell RJ, Robb ML, Michael NL, Vasan S, Thomas R. HLA-B∗46 associates with rapid HIV disease progression in Asian cohorts and prominent differences in NK cell phenotype. Cell Host Microbe. 2022 Aug 10;30(8):1173-1185.e8. doi: 10.1016/j.chom.2022.06.005. Epub 2022 Jul 15. PMID: 35841889.
Abucayon EG, Whalen C, Torres OB, Duval AJ, Sulima A, Antoline JFG, Oertel T, Barrientos RC, Jacobson AE, Rice KC, Matyas GR. A Rapid Method for Direct Quantification of Antibody Binding-Site Concentration in Serum. ACS Omega. 2022 Jul 19;7(30):26812-26823. doi: 10.1021/acsomega.2c03237. eCollection 2022 Aug 2. PMID: 35936462.
Streeck H, Maestri A, Habermann D, Crowell TA, Esber AL, Son G, Eller LA, Eller MA, Parikh AP, Horn PA, Maganga L, Bahemana E, Adamu Y, Kiweewa F, Maswai J, Owuoth J, Robb ML, Michael NL, Polyak CS, Hoffmann D, Ake JA; AFRICOS Study Group. Dissecting drivers of immune activation in chronic HIV-1 infection. EBioMedicine. 2022 Jul 26;83:104182. doi: 10.1016/j.ebiom.2022.104182. Online ahead of print. PMID: 35905559.
Walker-Sperling V, Digitale JC, Viard M, Martin MP, Bashirova A, Yuki Y, Ramsuran V, Kulkarni S, Naranbhai V, Li H, Anderson SK, Yum L, Clifford R, Kibuuka H, Ake J, Thomas R, Rowland-Jones S, Rek J, Arinaitwe E, Kamya M, Rodriguez-Barraquer I, Feeney ME, Carrington M. Genetic variation that determines TAPBP expression levels associates with the course of malaria in an HLA allotype-dependent manner. Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2205498119. doi: 10.1073/pnas.2205498119. Epub 2022 Jul 13. PMID: 35858344.
Kroidl I, Ahmed MIM, Horn S, Polyak C, Esber A, Parikh A, Eller LA, Kibuuka H, Semwogerere M, Mwesigwa B, Naluyima P, Kasumba JM, Maswai J, Owuoth J, Sing'oei V, Rono E, Loose R, Hoelscher M, Ake J, Geldmacher C; AFRICOS Study Group. Assessment of tuberculosis disease activity in people infected with Mycobacterium tuberculosis and living with HIV: A longitudinal cohort study. EClinicalMedicine. 2022 Jul 13;49:101470. doi: 10.1016/j.eclinm.2022.101470. eCollection 2022 Jul. PMID: 35873194.
Kibirige CN, Manak M, King D, Abel B, Hack H, Wooding D, Liu Y, Fernandez N, Dalel J, Kaye S, Imami N, Jagodzinski L, Gilmour J. Author Correction: Development of a sensitive, quantitative assay with broad subtype specificity for detection of total HIV-1 nucleic acids in plasma and PBMC. Sci Rep. 2022 Jul 11;12(1):11792. doi: 10.1038/s41598-022-16308-x. PMID: 35821052.
Waickman AT, Victor K, Newell K, Li T, Friberg H, Foulds KE, Roederer M, Bolton DL, Currier JR, Seder R. mRNA-1273 vaccination protects against SARS-CoV-2-elicited lung inflammation in nonhuman primates. JCI Insight. 2022 Jul 8;7(13):e160039. doi: 10.1172/jci.insight.160039. PMID: 35653196.
Shah N, Esber A, Sean Cavanaugh J, Agaba P, Dear N, Iroezindu M, Bahemana E, Kibuuka H, Owuoth J, Maswai J, Singoei V, Crowell TA, Polyak CS, Ake JA. Transitioning women to first-line preferred TLD regimen is lagging in Sub-Saharan Africa. Clin Infect Dis. 2022 Jul 5:ciac555. doi: 10.1093/cid/ciac555. Online ahead of print. PMID: 35788648.
LeeVan E, Hu F, Mitchell AB, Kokogho A, Adebajo S, Garges EC, Qian H, Ake JA, Robb ML, Charurat ME, Baral SD, Nowak RG, Crowell TA; TRUST/RV368 Study Group. Associations of gender identity with sexual behaviours, social stigma and sexually transmitted infections among adults who have sex with men in Abuja and Lagos, Nigeria. J Int AIDS Soc. 2022 Jul;25(7):e25956. doi: 10.1002/jia2.25956. PMID: 35794838.
King K, Balan S, Kanamori M, Shrader CH, Arroyo-Flores J, Johnson A, Whiteside P, Michniewicz M, Doblecki-Lewis S. Feasibility and Acceptability of HIV Self-Test Kit Distribution Through PrEP Clients' Social and Sexual Networks to Increase HIV Testing and PrEP Information. J Acquir Immune Defic Syndr. 2022 Jul 1;90(S1):S105-S113. doi: 10.1097/QAI.0000000000002970. PMID: 35703762.
Andagalu B, Watson OJ, Onyango I, Opot B, Okoth R, Chemwor G, Sifuna P, Juma D, Cheruiyot A, Yeda R, Okudo C, Wafubwa J, Yalwala S, Abuom D, Ogutu B, Cowden J, Akala HM, Kamau E. Malaria Transmission Dynamics in High Transmission Setting of Western Kenya and the Inadequate Treatment Response to Artemether-lumefantrine in an Asymptomatic Population. Clin Infect Dis. 2022 Jun 29:ciac527. doi: 10.1093/cid/ciac527. Online ahead of print. PMID: 35767269.
Tokarev A, Machmach K, Creegan M, Kim D, Eller MA, Bolton DL. Single-Cell Profiling of Latently SIV-Infected CD4+ T Cells Directly Ex Vivo to Reveal Host Factors Supporting Reservoir Persistence. Microbiol Spectr. 2022 Jun 29;10(3):e0060422. doi: 10.1128/spectrum.00604-22. Epub 2022 May 5. PMID: 35510859.
Crowell TA, Nitayaphan S, Sirisopana N, Wansom T, Kitsiripornchai S, Francisco L, Li Q, Dear N, O'Connell RJ, Pitisuttithum P, Vasan S; RV348B Study Group. Factors associated with testing for HIV and other sexually transmitted infections in men who have sex with men and transgender women in Bangkok, Thailand. AIDS Res Ther. 2022 Jun 21;19(1):25. doi: 10.1186/s12981-022-00449-0. PMID: 35729561.
Walker-Sperling VEK, Mercado NB, Chandrashekar A, Borducchi EN, Liu J, Nkolola JP, Lewis M, Murry JP, Yang Y, Geleziunas R, Robb ML, Michael NL, Pau MG, Wegmann F, Schuitemaker H, Fray EJ, Kumar MR, Siliciano JD, Siliciano RF, Barouch DH. Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques. Nat Commun. 2022 Jun 16;13(1):3463. doi: 10.1038/s41467-022-31196-5. PMID: 35710819.
Welles HC, King HAD, Nettey L, Cavett N, Gorman J, Zhou T, Tsybovsky Y, Du R, Song K, Nguyen R, Ambrozak D, Ransier A, Schramm CA, Doria-Rose NA, Swanstrom AE, Hoxie JA, LaBranche C, Montefiori DC, Douek DC, Kwong PD, Mascola JR, Roederer M, Mason RD. Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4. PLoS Pathog. 2022 Jun 16;18(6):e1010574. doi: 10.1371/journal.ppat.1010574. Online ahead of print. PMID: 35709309.
Kroon E, Chottanapund S, Buranapraditkun S, Sacdalan C, Colby DJ, Chomchey N, Prueksakaew P, Pinyakorn S, Trichavaroj R, Vasan S, Manasnayakorn S, Reilly C, Helgeson E, Anderson J, David C, Zulk J, de Souza M, Tovanabutra S, Schuetz A, Robb ML, Douek DC, Phanuphak N, Haase A, Ananworanich J, Schacker TW. Paradoxically Greater Persistence of HIV RNA-Positive Cells in Lymphoid Tissue When ART Is Initiated in the Earliest Stage of Infection. J Infect Dis. 2022 Jun 15;225(12):2167-2175. doi: 10.1093/infdis/jiac089. PMID: 35275599.
Chan P, Yoon B, Colby D, Kroon E, Sacdalan C, Sriplienchan S, Pinyakorn S, Ananworanich J, Valcour V, Vasan S, Hsu D, Phanuphak N, Paul R, Spudich S. Immunological, Cognitive and Psychiatric Outcomes after Initiating EFV- and DTG-based Antiretroviral Therapy during Acute HIV Infection. Clin Infect Dis. 2022 Jun 10:ciac466. doi: 10.1093/cid/ciac466. Online ahead of print .PMID: 35687498.
Waickman AT, Victor K, Newell K, Li T, Friberg H, Foulds KE, Roederer M, Bolton DL, Currier JR, Seder R. mRNA-1273 vaccination protects against SARS-CoV-2 elicited lung inflammation in non-human primates. JCI Insight. 2022 Jun 2:e160039. doi: 10.1172/jci.insight.160039. Online ahead of print. PMID: 35653196.
Fletcher CV, Kroon E, Schacker T, Pinyakorn S, Chomont N, Chottanapund S, Prueksakaew P, Benjapornpong K, Buranapraditkun S, Phanuphak N, Ananworanich J, Vasan S, Hsu D; RV254/SEARCH 010 study Group. Persistent HIV transcription and variable antiretroviral drug penetration in lymph nodes during plasma viral suppression. AIDS. 2022 Jun 1;36(7):985-990. doi: 10.1097/QAD.0000000000003201. Epub 2022 Feb 18. PMID: 35184069.
Kamau E, Chaudhury S, Bolton JS, Slike BM, Jian N, Eller MA, Eller LA, Ake J, Robb ML, Krebs SJ, Bergmann-Leitner ES. Susceptibility to HIV-1 Acquisition linked to Malaria Exposure: A Case-control Study. Clin Infect Dis. 2022 May 20:ciac384. doi: 10.1093/cid/ciac384. Online ahead of print. PMID: 35594548.
Ventura JD, Nkolola JP, Chandrashekar A, Borducchi EN, Liu J, Mercado NB, Hope DL, Giffin VM, McMahan K, Geleziunas R, Murry JP, Yang Y, Lewis MG, Pau MG, Wegmann F, Schuitemaker H, Fray EJ, Kumar MR, Siliciano JD, Siliciano RF, Robb ML, Michael NL, Barouch DH. Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques. NPJ Vaccines. 2022 May 18;7(1):53. doi: 10.1038/s41541-022-00477-x. PMID: 35585080.
Jobe O, Kim J, Pinto DO, Villar Z, Hewitt T, Duncan EH, Anderson A, Gohain N, Gong H, Tucker C, Alving CR, Matyas GR, Bergmann-Leitner E, Rao M. Army liposome formulation containing QS-21 render human monocyte-derived macrophages less permissive to HIV-1 infection by upregulating ABOBEC3A. Sci Rep. 2022 May 9;12(1):7570. doi: 10.1038/s41598-022-11230-8. PMID: 35534646.
Tokarev A, Machmach K, Creegan M, Kim D, Eller MA, Bolton DL. Single-Cell Profiling of Latently SIV-Infected CD4+ T Cells Directly Ex Vivo to Reveal Host Factors Supporting Reservoir Persistence. Microbiol Spectr. 2022 May 5:e0060422. doi: 10.1128/spectrum.00604-22. Online ahead of print.PMID: 35510859.
El Bouzidi K, Murtala-Ibrahim F, Kwaghe V, Datir RP, Ogbanufe O, Crowell TA, Charurat M, Dakum P, Gupta RK, Ndembi N, Sabin CA. Disengagement From HIV Care and Failure of Second-Line Therapy in Nigeria: A Retrospective Cohort Study, 2005-2017. J Acquir Immune Defic Syndr. 2022 May 1;90(1):88-96. doi: 10.1097/QAI.0000000000002918.PMID: 35090157.
Peay HL, Rennie S, Cadigan RJ, Gwaltney A, Jupimai T, Phanuphak N, Kroon E, Colby DJ, Ormsby N, Isaacson SC, Vasan S, Sacdalan C, Prueksakaew P, Benjapornpong K, Ananworanich J, Henderson GE. Attitudes About Analytic Treatment Interruption (ATI) in HIV Remission Trials with Different Antiretroviral Therapy (ART) Resumption Criteria. AIDS Behav. 2022 May;26(5):1504-1516. doi: 10.1007/s10461-021-03504-5. Epub 2022 Jan 8.PMID: 34997386.
Monroe AK, Polyak CS, Castel AD, Esber AL, Byrne ME, Maswai J, Owuoth J, Maganga L, Bahemana E, Adamu Y, Iroezindu M, Kibuuka H, Kiweewa F, Greenberg AE, Crowell TA, Ake JA; DC Cohort Executive Committee and AFRICOS Study Group. Clinical similarities and differences between two large HIV cohorts in the United States and Africa. PLoS One. 2022 Apr 4;17(4):e0262204. doi: 10.1371/journal.pone.0262204. eCollection 2022.PMID: 35377881.
Kunz A, Moodley A, Colby DJ, Soltis M, Robb-McGrath W, Fairchok A, Faestel P, Jungels A, Bender AA, Kamau E, Wingood G, DiClemente R, Scott P. Feasibility, acceptability, and short-term impact of a brief sexually transmitted infection intervention targeting U.S. Military personnel and family members. BMC Public Health. 2022 Apr 2;22(1):640. doi: 10.1186/s12889-022-13096-x.PMID: 35366848.
Esber AL, Chang D, Iroezindu M, Bahemana E, Kibuuka H, Owuoth J, Singoei V, Maswai J, Dear NF, Crowell TA, Polyak CS, Ake JA; AFRICOS Study Group. Weight gain during the dolutegravir transition in the African Cohort Study. J Int AIDS Soc. 2022 Apr;25(4):e25899. doi: 10.1002/jia2.25899.PMID: 35419973.
Streeck H, Jansen K, Crowell TA, Esber A, Jessen HK, Cordes C, Scholten S, Schneeweiss S, Brockmeyer N, Spinner CD, Bickel M, Esser S, Hartikainen J, Stoehr A, Lehmann C, Marcus U, Vehreschild JJ, Knorr A, Brillen AL, Tiemann C, Robb ML, Michael NL. HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019. Euro Surveill. 2022 Apr;27(14):2100591. doi: 10.2807/1560-7917.ES.2022.27.14.2100591.PMID: 35393933.
Onyenakie CC, Nnakwe RU, Dear N, Esber A, Bahemana E, Kibuuka H, Maswai J, Owuoth J, Crowell TA, Polyak CS, Ake JA, Iroezindu M; AFRICOS Study Group. Prevalence and predictors of food insecurity among people living with and without HIV in the African Cohort Study. Public Health Nutr. 2022 Apr;25(4):930-943. doi: 10.1017/S136898002100361X. Epub 2021 Aug 23. PMID: 34420547.
Lewitus E, Townsley SM, Li Y, Donofrio GC, Dearlove BL, Bai H, Sanders-Buell E, O'Sullivan AM, Bose M, Kibuuka H, Maganga L, Nitayaphan S, Sawe FK, Eller LA, Michael NL, Polonis VR, Ake JA, Vasan S, Robb ML, Tovanabutra S, Krebs SJ, Rolland M. HIV-1 infections with multiple founders associate with the development of neutralization breadth. PLoS Pathog. 2022 Mar 18;18(3):e1010369. doi: 10.1371/journal.ppat.1010369. Online ahead of print. PMID: 35303045.
Matavele Chissumba R, Magul C, Macamo R, Monteiro V, Enosse M, Macicame I, Cumbane V, Bhatt N, Viegas E, Imbach M, Eller LA, Polyak CS, Kestens L; RV363 Study Group. Helios expressing regulatory T cells are correlated with decreased IL-2 producing CD8 T cells and antibody diversity in Mozambican individuals living chronically with HIV-1. BMC Immunol. 2022 Mar 14;23(1):12. doi: 10.1186/s12865-022-00487-3. PMID: 35287587.
Kroon E, Chottanapund S, Buranapraditkun S, Sacdalan C, Colby DJ, Chomchey N, Prueksakaew P, Pinyakorn S, Trichavaroj R, Vasan S, Manasnayakorn S, Reilly C, Helgeson E, Anderson J, David C, Zulk J, de Souza M, Tovanabutra S, Schuetz A, Robb ML, Douek DC, Phanuphak N, Haase A, Ananworanich J, Schacker TW. Paradoxically greater persistence of HIV RNA+ cells in lymphoid tissue when ART is initiated in the earliest stage of infection. J Infect Dis. 2022 Mar 11:jiac089. doi: 10.1093/infdis/jiac089. Online ahead of print.PMID: 35275599.
Sulima A, Li F, Morgan JB, Truong P, Antoline JFG, Oertel T, Barrientos RC, Torres OB, Beck Z, Imler GH, Deschamps JR, Matyas GR, Jacobson AE, Rice KC. Design, Synthesis, and In Vivo Evaluation of C1-Linked 4,5-Epoxymorphinan Haptens for Heroin Vaccines. Molecules. 2022 Feb 25;27(5):1553. doi: 10.3390/molecules27051553. PMID: 35268659.
Fletcher CV, Kroon E, Schacker T, Pinyakorn S, Chomont N, Chottanapund S, Prueksakaew P, Benjapornpong K, Buranapraditkun S, Phanuphak N, Ananworanich J, Vasan S, Hsu D; RV254/SEARCH 010 study Group. Persistent HIV transcription and Variable ARV penetration in lymph nodes during plasma viral suppression. AIDS. 2022 Feb 18. doi: 10.1097/QAD.0000000000003201. Online ahead of print. PMID: 35184069.
Joyce MG, King HAD, Elakhal-Naouar I, Ahmed A, Peachman KK, Macedo Cincotta C, Subra C, Chen RE, Thomas PV, Chen WH, Sankhala RS, Hajduczki A, Martinez EJ, Peterson CE, Chang WC, Choe M, Smith C, Lee PJ, Headley JA, Taddese MG, Elyard HA, Cook A, Anderson A, McGuckin Wuertz K, Dong M, Swafford I, Case JB, Currier JR, Lal KG, Molnar S, Nair MS, Dussupt V, Daye SP, Zeng X, Barkei EK, Staples HM, Alfson K, Carrion R, Krebs SJ, Paquin-Proulx D, Karasavva N, Polonis VR, Jagodzinski LL, Amare MF, Vasan S, Scott PT, Huang Y, Ho DD, de Val N, Diamond MS, Lewis MG, Rao M, Matyas GR, Gromowski GD, Peel SA, Michael NL, Bolton DL, Modjarrad K. A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates. Sci Transl Med. 2022 Feb 16;14(632):eabi5735. doi: 10.1126/scitranslmed.abi5735. Epub 2022 Feb 16. PMID: 34914540.
Swan DA, Rolland M, Herbeck JT, Schiffer JT, Reeves DB. Evolution during primary HIV infection does not require adaptive immune selection. Proc Natl Acad Sci U S A. 2022 Feb 15;119(7):e2109172119. doi: 10.1073/pnas.2109172119. PMID: 35145025.
Hsu DC, Chumpolkulwong K, Corley MJ, Hunsawong T, Inthawong D, Schuetz A, Imerbsin R, Silsorn D, Nadee P, Sopanaporn J, Phuang-Ngern Y, Klungthong C, Reed M, Fernandez S, Ndhlovu LC, Paul R, Lugo-Roman L, Michael NL, Modjarrad K, Vasan S. Neurocognitive impact of Zika virus infection in adult rhesus macaques. J Neuroinflammation. 2022 Feb 7;19(1):40. doi: 10.1186/s12974-022-02402-4. PMID: 35130924.
Letizia AG, Eller LA, Bryant C, Dawson P, Nitayaphan S, Kosgei J, Kibuuka H, Maganga L, Kroon E, Sriplienchan S, Michael NL, O'Connell RJ, Kim JH, Robb ML; RV 217 Study Team. Clinical signs and symptoms associated with acute HIV infection from an intensely monitored cohort on 2 continents. Medicine (Baltimore). 2022 Feb 4;101(5):e28686. doi: 10.1097/MD.0000000000028686. PMID: 35119011.
Tsikhutsu I, Bii M, Dear N, Ganesan K, Kasembeli A, Sing'oei V, Romboisia K, Ochieng C, Desai P, Wolfman V, Coakley P, Lee EH, Hickey PW, Livezey J, Agaba P. Prevalence and Correlates of Viral Load Suppression and HIV Drug Resistance Among Children and Adolescents in South Rift Valley and Kisumu, Kenya. Clin Infect Dis. 2022 Jan 29:ciac059. doi: 10.1093/cid/ciac059. Online ahead of print. PMID: 35092424.
Kibirige CN, Manak M, King D, Abel B, Hack H, Wooding D, Liu Y, Fernandez N, Dalel J, Kaye S, Imami N, Jagodzinski L, Gilmour J. Development of a sensitive, quantitative assay with broad subtype specificity for detection of total HIV-1 nucleic acids in plasma and PBMC. Sci Rep. 2022 Jan 28;12(1):1550. doi: 10.1038/s41598-021-03016-1. PMID: 35091568.
Shepherd BO, Chang D, Vasan S, Ake J, Modjarrad K. HIV and SARS-CoV-2: Tracing a Path of Vaccine Research and Development. Curr HIV/AIDS Rep. 2022 Jan 28:1-8. doi: 10.1007/s11904-021-00597-4. Online ahead of print. PMID: 35089535.
Langowski MD, Khan FA, Savransky S, Brown DR, Balasubramaniyam A, Harrison WB, Zou X, Beck Z, Matyas GR, Regules JA, Miller R, Soisson LA, Batchelor AH, Dutta S. Restricted valency (NPNA)n repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparum. NPJ Vaccines. 2022 Jan 27;7(1):13. doi: 10.1038/s41541-022-00430-y. PMID: 35087099.
El Bouzidi K, Murtala-Ibrahim F, Kwaghe V, Datir RP, Ogbanufe O, Crowell TA, Charurat M, Dakum P, Gupta RK, Ndembi N, Sabin CA. Disengagement from HIV care and failure of second-line therapy in Nigeria: a retrospective cohort study, 2005-2017. J Acquir Immune Defic Syndr. 2022 Jan 26. doi: 10.1097/QAI.0000000000002918. Online ahead of print. PMID: 35090157.
Yu J, Collins ND, Mercado NB, McMahan K, Chandrashekar A, Liu J, Anioke T, Chang A, Giffin VM, Hope DL, Sellers D, Nampanya F, Gardner S, Barrett J, Wan H, Velasco J, Teow E, Cook A, Van Ry A, Pessaint L, Andersen H, Lewis MG, Hofer C, Burke DS, Barkei EK, King HAD, Subra C, Bolton D, Modjarrad K, Michael NL, Barouch DH. Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques. J Virol. 2022 Jan 26;96(2):e0159921. doi: 10.1128/JVI.01599-21. Epub 2021 Oct 27. PMID: 34705557.
Noiman A, Esber A, Wang X, Bahemana E, Adamu Y, Iroezindu M, Kiweewa F, Maswai J, Owuoth J, Maganga L, Ganesan A, Maves RC, Lalani T, Colombo RE, Okulicz JF, Polyak C, Crowell TA, Ake JA, Agan BK. Clinical factors and outcomes associated with immune non-response among virally suppressed adults with HIV from Africa and the United States. Sci Rep. 2022 Jan 24;12(1):1196. doi: 10.1038/s41598-022-04866-z.PMID: 35075147.
Peay HL, Rennie S, Cadigan RJ, Gwaltney A, Jupimai T, Phanuphak N, Kroon E, Colby DJ, Ormsby N, Isaacson SC, Vasan S, Sacdalan C, Prueksakaew P, Benjapornpong K, Ananworanich J, Henderson GE. Attitudes About Analytic Treatment Interruption (ATI) in HIV Remission Trials with Different Antiretroviral Therapy (ART) Resumption Criteria. AIDS Behav. 2022 Jan 8. doi: 10.1007/s10461-021-03504-5. Online ahead of print. PMID: 34997386.
Dear N, Esber A, Iroezindu M, Bahemana E, Kibuuka H, Maswai J, Owuoth J, Polyak CS, Ake JA, Crowell TA; AFRICOS Study Group. Routine HIV clinic visit adherence in the African Cohort Study. AIDS Res Ther. 2022 Jan 7;19(1):1. doi: 10.1186/s12981-021-00425-0. PMID: 34996470.
Holtzman CW, Godfrey C, Ismail L, Raizes E, Ake JA, Tefera F, Okutoyi S, Siberry GK. PEPFAR's Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa. Curr HIV/AIDS Rep. 2022 Jan 4:1-11. doi: 10.1007/s11904-021-00587-6. Online ahead of print. PMID: 34982406.
Mitchell JL, Pollara J, Dietze K, Edwards RW, Nohara J, N'guessan KF, Zemil M, Buranapraditkun S, Takata H, Li Y, Muir R, Kroon E, Pinyakorn S, Jha S, Manasnayakorn S, Chottanapund S, Thantiworasit P, Prueksakaew P, Ratnaratorn N, Nuntapinit B, Fox L, Tovanabutra S, Paquin-Proulx D, Wieczorek L, Polonis VR, Maldarelli F, Haddad EK, Phanuphak P, Sacdalan CP, Rolland M, Phanuphak N, Ananworanich J, Vasan S, Ferrari G, Trautmann L; RV254 and RV304 Study Groups. Anti-HIV antibody development up to 1 year after antiretroviral therapy initiation in acute HIV infection. J Clin Invest. 2022 Jan 4;132(1):e150937. doi: 10.1172/JCI150937. PMID: 34762600.
Thomas R, Chansinghakul D, Limkittikul K, Gilbert PB, Hattasingh W, Moodie Z, Shangguan S, Frago C, Dulyachai W, Li SS, Jarman RG, Geretz A, Bouckenooghe A, Sabchareon A, Juraska M, Ehrenberg P, Michael NL, Bailleux F, Bryant C, Gurunathan S. Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in Thailand. Hum Immunol. 2022 Jan;83(1):53-60. doi: 10.1016/j.humimm.2021.09.006. Epub 2021 Oct 8. PMID: 34635391.
Oluniyi PE, Ajogbasile FV, Zhou S, Fred-Akintunwa I, Polyak CS, Ake JA, Tovanabutra S, Iroezindu M, Rolland M, Happi CT. HIV-1 drug resistance and genetic diversity in a cohort of people with HIV-1 in Nigeria. AIDS. 2022 Jan 1;36(1):137-146. doi: 10.1097/QAD.0000000000003098. PMID: 34628443.
Esber A, Dear N, Reed D, Bahemana E, Owouth J, Maswai J, Kibuuka H, Iroezindu M, Crowell TA, Polyak CS, Akom E, Ake JA; AFRICOS Study Group. Temporal trends in self-reported HIV stigma and association with adherence and viral suppression in the African Cohort Study. AIDS Care. 2022 Jan;34(1):78-85. doi: 10.1080/09540121.2021.1984380. Epub 2021 Oct 6. PMID: 34612100.